Header Logo

Connection

POOJA POPLI to Immunotherapy

Back to Details
This is a "connection" page, showing publications POOJA POPLI has written about Immunotherapy.
POOJA POPLI
Connection Strength
0.124
Immunotherapy
  1. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 2022 02; 7(1):100336.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.